Zhuhai Rundu Pharmaceutical (002923.SZ): The hydrochloride of meperidine injection obtained the drug registration certificate.
Runthu Group (002923.SZ) announcement: The company has received the "Drug Registration Certificate" issued by the National Medical Products Administration for the injection of methylergometrine maleate. This product is used for cardiac stress testing, suitable for myocardial perfusion imaging (MPI) to evaluate myocardial ischemia.
Zhuhai Rundu Pharmaceutical (002923.SZ) annonuced that the company has received the Drug Registration Certificate for the injection of Desmethyllevomilnacipran Hydrochloride issued by the National Medical Products Administration. This product is a drug used for cardiac load testing and is suitable for Myocardial Perfusion Imaging (MPI) to evaluate myocardial ischemia.
Related Articles

Zhixiang Jintai (688443.SH) plans to launch a restricted stock incentive plan in 2026.

Wuchan Zhongda Group plans to repurchase shares worth 200 million to 400 million yuan.

WELLE Environmental Group (300190.SZ) has won the bidding for a sewage treatment project worth 44.88 million yuan.
Zhixiang Jintai (688443.SH) plans to launch a restricted stock incentive plan in 2026.

Wuchan Zhongda Group plans to repurchase shares worth 200 million to 400 million yuan.

WELLE Environmental Group (300190.SZ) has won the bidding for a sewage treatment project worth 44.88 million yuan.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


